Chris Beyrer, MD, MPH

Associate Professor, Johns Hopkins Bloomberg School of Public Health

Chris Beyrer is an associate research professor in the Department of Epidemiology in the Johns Hopkins Bloomberg School of Public Health. He has a joint appointment in the Department of International Health. Dr. Beyrer received his medical degree from the S.U.N.Y. Health Sciences Center at Brooklyn and his MPH from the Johns Hopkins Bloomberg School of Public Health.

Dr. Beyrer has worked as a staff epidemiologist at the Pan American Health Organization, Expanded Programme on Immunization (EPI) in Jamaica, Trinidad & Tobago; as a visiting researcher at NIH, NIAID, Division of Microbiology and Infectious Diseases; and as a study physician in the Center for Native American Health of Johns Hopkins University in Whiteriver, AZ.

Currently, Dr. Beyrer is the director of the JHU Fogarty AIDS International Training and Research Program and the JHU Fogarty Tuberculosis International Training and Research Program. He is also the senior scientific liaison for Asia and Africa, HIV Vaccine Trials Network.

Ami Shah Brown, PhD, MPH

Regulatory Affairs Manager, Johns Hopkins Bloomberg School of Public Health

Ami Shah Brown received her PhD in the Department of International Health at Johns Hopkins Bloomberg School of Public Health and is currently heading the Regulatory Affairs Division for the Sabin Vaccine Institute's Human Hookworm Vaccine Initiative. She has a master of public health degree from The Rollins School of Public Health of Emory University with a focus in behavioral sciences and health education and BA in biology from the University of Pennsylvania. Before joining the Sabin Vaccine Institute, Dr. Brown worked as a senior research program coordinator in the Center for Immunization Research at the Johns Hopkins Bloomberg School of Public Health. Other experience includes laboratory and community work on various HIV vaccine trials, a fellowship with the Centers for Disease Control and Prevention's (CDC) National Centers for HIV, STD, and TB prevention (NCHSTP) to develop measures for behavioral surveillance, and with the Emory Vaccines Center, where she designed the community education and recruitment plan for HIV vaccine trials.

Donald S. Burke, MD

Professor, Johns Hopkins Bloomberg School of Public Health

Donald A. Burke is professor of international health and epidemiology and director of the Center for Immunization Research at the Johns Hopkins Bloomberg School of Public Health.

Dr. Burke received his BA from Western Reserve University in 1967 and his MD from Harvard Medical School in 1971. His post-graduate medical training was in internal medicine at the Boston City Hospital and the Massachusetts General Hospital, and in infectious diseases at the Walter Reed Army Medical Center. Dr. Burke served on active duty in the U.S. Army Medical Research and Development Command for 23 years. He held assignments at the US Army Medical Research Institute of Infectious Diseases in Frederick Maryland (197375) at the Armed Forces Research Institute of Infectious Diseases in Bangkok, Thailand (197884) and at the Walter Reed Army Institute of Research in Washington, D.C. (197678 and 198497). Throughout his career, he developed new methods to prevent and control viral infections of global importance, focusing on tropical infections such as dengue, Japanese encephalitis, hepatitis A, and HIV/AIDS. He has conducted basic laboratory research, epidemiological research, clinical vaccine studies, and field vaccine trials. He has worked in high-containment facilities and in remote tropical research stations, and he has personally volunteered as a research subject in several vaccine trials. He joined the Johns Hopkins faculty in 1997.

Dr. Burke has served on numerous advisory boards and councils for NIH, CDC, WHO, and other national and international agencies. He has published over 200 articles and chapters in medical and scientific journals. He was instrumental in founding the Civil-Military Alliance Against HIV/AIDS, and the International AIDS Vaccine Initiative. He is a past president of the American Society of Tropical Medicine and Hygiene, a fellow of the American College of Physicians, and a fellow of the Infectious Diseases Society of America.

Roberta (Bobbie) Casey, BS, MS

Research Associate, Johns Hopkins Bloomberg School of Public Health

Roberta Casey earned a bachelor of science in nursing from the University of Maryland and a master of science in nursing from Catholic University of America. After completing the program, Mrs. Casey was certified as a pediatric nurse practitioner.

From 1984 to the present, Mrs. Casey has worked with the faculty and staff of the Center for Immunization Research and followed a cohort of patients in the Harriet Lane Clinic at the Johns Hopkins Hospital. She also functioned as the RSV pediatric program coordinator for the Center for Immunization Research, working closely with the principal investigator, Dr. Ruth Karron, on multiple vaccine protocols. In June, 2000, she was appointed as a research associate in the Department of International Health, Division of Disease Control, of the Bloomberg School of Public Health.

Her current role involves coordination of all aspects of pediatric vaccine research trials at the Center for Immunization Research. A few important aspects of this position include the following: Education of investigators and staff in the conduct of vaccine clinical trials; IRB submissions; development of study-specific educational, recruitment, and data-collection tools; medical evaluation of pediatric vaccine volunteers; clinical trial management; and supervision of clinical staff. She is also principal investigator of a protocol "Antibody Screening of Potential Participants in Studies to Evaluate New Vaccines, Antimicrobial Agents, and Infectious Agents." Other research interests include informed consent and ethics in the research setting.

Nedra Davis, BS

Community Education/Recruitment Assistant, Johns Hopkins Bloomberg School of Public Health

Nedra Davis is currently the Community Education/Recruitment Assistant for the Johns Hopkins University HIV Vaccine Trial Unit (HVTU). She is part of a team which is responsible for educating and creating awareness in the Baltimore and DC area about preventive HIV vaccine clinical trials. Previously, she was involved in educating individuals on the issues of reproductive health and HIV/AIDS. She earned a bachelors of science degree at Towson University in health science with a concentration in community health education.

Anna Durbin, MD

Assistant Professor, Johns Hopkins Bloomberg School of Public Health

Anna Durbin is an assistant professor in the Division of Disease Control, Department of International Health, in the Bloomberg School of Public Health. She has a joint appointment in the Department of Medicine in the Johns Hopkins School of Medicine. Dr. Durbin received her BS from the University of Michigan in 1983 and her MD from Wayne State University in 1987. Her postgraduate medical training was in internal medicine and infectious diseases at the Detroit Medical Center, Wayne State University. From 19941999, she was a clinical fellow in the Respiratory Viruses Section of the NIAID/NIH, where she used recombinant DNA technology to design and recover novel live attenuated parainfluenza virus vaccine candidates.

Dr. Durbin joined the faculty of the Johns Hopkins Bloomberg School of Public Health in 1999. At the Center for Immunization Research, she has been the principal investigator for Phase I and II trials of live attenuated dengue virus vaccine candidates. She is the clinical director of the Inpatient Isolation Unit located on the Bayview Medical Campus. Dr. Durbin also has experience in conducting challenge studies of enteric pathogens in collaboration with the Vaccine Testing Unit at the Johns Hopkins Bloomberg School of Public Health.

Paul W. Goebel, Jr.

Vice President, Chesapeake Research Review, Inc.

Neal A. Halsey, MD

Professor, Department of International Health, Johns Hopkins Bloomberg School of Public Health

Clayton D. Harro, MD, ScM

Assistant Scientist, Johns Hopkins Bloomberg School of Public Health

Hye Y. Kim, RPh

Investigational Drug Pharmacist

Vivian Rexroad, PharmD

Research Pharmacist, Investigational Drug Service

Theron Scott

Community Education/Recruitment Coordinator, Johns Hopkins Bloomberg School of Public Health

Theron Scott is a lifelong resident of Baltimore, Maryland. He attended Towson State University, where he majored in business administration. In 1993, family and personal circumstances led him to the HIV/AIDS field. He has worked as an HIV counselor, educator, and outreach worker at Bon Secours Health Systems and New Hope Treatment Center in Baltimore. He has worked at the Johns Hopkins HIV Vaccine Trials Unit since 1999 and is currently charged with raising the level of awareness and education regarding HIV-prevention vaccines in communities throughout the Baltimore/Washington metro areas. In the words of Mr. Scott, "Being part of a international team that is working towards the development of a safe, effective, accessible HIV prevention vaccine far surpasses any of my prior goals."

Elizabeth Schappell, RN, BSN, CCRP

Clinical Research Program Coordinator, Johns Hopkins Bloomberg School of Public Health

Elizabeth (Betty) Schappell is a clinical research program coordinator at the Center for Immunization Research and a co-investigator for pediatric vaccine trials. An RN since 1993, she received a BS in nursing in 2005. She also received research certification through the Society of Clinical Research Associates in 2002. Betty has been involved in Phase I and II pediatric respiratory vaccine studies since 1998 and Phase I adult inpatient avian flu trials in 2005. However, her heart belongs to pediatrics, and she is returning to pediatric trials.

Mary Jane Reynolds, RN, CS, MSN, FNP

Nurse Consultant, National Institutes of Health (NIH)

Mary Jane Reynolds is a nurse consultant for the National Institutes of Health (NIH), Division of AIDS with the Vaccine and Prevention Research Program, Vaccine Clinical Research Branch. She is an associate faculty member of the Johns Hopkins Bloomberg School of Public Health in the International Health Department. Ms. Reynolds received a master of science in nursing from Georgetown University, and she is a certified family nurse practitioner (FNP).

Prior to accepting her appointment at NIH, she was the director of Clinical Trials Operations at the JHU Center for Immunization Research (CIR). In this position, she was responsible for the coordination and conduct of clinical vaccine trials at CIR. Ms. Reynolds was involved in all aspects of trial conductespecially protocol and consent form development, pre-study evaluation of vaccine trial participants, and adverse event evaluation. She was principal investigator for a long-term follow-up protocol for vaccine volunteers and a sub-investigator on all CIR protocols. Her clinical trial experience involved a variety of Phase I to Phase III trials in inpatient and outpatient settings to evaluate vaccines such as preventive HIV/AIDS; hepatitis A, B, and C; human papilloma virus; influenza; respiratory syncytial virus; parainfluenza; rotavirus; and dengue.

Because training JHU and non-JHU faculty, principal investigators, and staff became an integral part of their work, Mary Jane Reynolds and Karen Charron set a goal in 1998 to design an educational program to standardize the training process. As a result of this goal, Ms. Reynolds and Ms. Charron co-authored and co-developed the Clinical Vaccine Trials: Planning and Implementation course. Ms. Reynolds remains a major contributor to the lectures in the current offering of this course.

Kathy Gilmore Campbell

Kathy Gilmore is a graduate of Johns Hopkins University. Ms. Gilmore worked as a student assistant at the Center for Immunization research from 1999-2000. During this period, she helped recruit and screen volunteers for a human papilloma virus vaccine trial. In May, 2000, she began working with the development team of Clinical Vaccine Trials. Ms. Gilmore provided essential production and design support for a large portion of lectures and materials of Clinical Vaccine Trials. Post graduation, she currently worked as a research assistant at the Department of Defense Center for Deployment Health Research at the Naval Health Research Center in San Diego, C, coordinating epidemiological studies to investigate the health experiences of military personnel and their families.

Research Associate, Center for American Indian Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health

Eugene Millar is a research associate in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health. He received an MS in bacteriology from the University of Wisconsin-Madison (1995), and an MHS in infectious disease epidemiology from the Department of Epidemiology (2000) and a PhD from the Department of International Health (2003) at the Johns Hopkins Bloomberg School of Public Health.

Dr. Millar's research interests are in the epidemiology of vaccine-preventable diseases of childhood, particularly among Native American populations. His doctoral dissertation evaluated the natural history of pneumococcal colonization, as well as the impact of pneumococcal conjugate vaccines on colonization, among Navajo and White Mountain Apache children. He also completed an internship in the Child Vaccine-Preventable Diseases Branch of the National Immunization Program, Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, and has served as a technical advisor to the World Health Organization (WHO) in Geneva, Switzerland. Dr. Millar was a co-developer of the content and format of Clinical Vaccine Trials. His hard work, creativity, and skills were instrumental in producing the quality lectures and materials presented in this course.